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Abstract 1 
Objectives: To compare the diagnostic accuracy of visual and quantitative analyses of 2 
myocardial perfusion cardiovascular magnetic resonance (CMR) against a reference standard of 3 
quantitative coronary angiography.  4 
Background: Visual analysis of perfusion CMR studies for assessing myocardial perfusion has 5 
been shown to have high diagnostic accuracy for coronary artery disease. However, only a few 6 
small studies have assessed the diagnostic accuracy of quantitative myocardial perfusion. 7 
Methods: This retrospective study included 128 patients randomly selected from the CE-MARC 8 
population such that the distribution of risk factors and disease status was proportionate to the 9 
full population. Visual analysis results of CMR perfusion images, by consensus of two expert 10 
readers, were taken from the original study reports. Quantitative myocardial blood flow (MBF) 11 
estimates were obtained using Fermi-constrained deconvolution. The reference standard for 12 
myocardial ischaemia was a quantitative coronary X-ray angiogram (QCA) stenosis severity of 13 
≥70% diameter in any coronary artery of >2mm diameter, or ≥50% in the left main stem. 14 
Diagnostic performance was calculated using receiver operator characteristic (ROC) curve 15 
analysis. 16 
Results: The AUC for visual analysis was 0.88 (95% confidence interval: 0.81, 0.95) with a 17 
sensitivity of 81.0% (95% confidence interval: 69.1%, 92.8%) and specificity of 86.0% (95% 18 
confidence interval: 78.7%, 93.4%). For quantitative stress MBF the AUC was 0.89 (95% 19 
confidence interval: 0.83, 0.96) with a sensitivity of 87.5% (95% confidence interval: 77.3%, 20 
97.7%) and specificity of 84.5% (95% confidence interval: 76.8%, 92.3%). There was no 21 
statistically significant difference between the diagnostic performance of quantitative and visual 22 
analyses (p=0.72). Incorporating rest MBF values to generate an MPR did not significantly 23 
increase the quantitative analysis AUC (p=0.79). 24 
Conclusions: Quantitative perfusion has a high diagnostic accuracy for detecting coronary artery 25 
disease, but is not superior to visual analysis. The incorporation of rest perfusion imaging does 26 
not improve diagnostic accuracy in quantitative perfusion analysis.   27 
 28 
Key words: cardiovascular magnetic resonance, myocardial ischaemia, quantitative myocardial 29 
perfusion, diagnostic accuracy 30 
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Introduction 1 
Cardiovascular Magnetic Resonance (CMR) is a well-established technique for the assessment of 2 
patients with coronary artery disease (CAD), being diagnostically superior (1,2), cost effective 3 
(3,4) and a better predictor of cardiovascular events (5) than myocardial perfusion scintigraphy 4 
by single-photon emission computed tomography (SPECT). CMR compares favourably with 5 
positron emission tomography (PET) (6), has higher image resolution, is more widely available, 6 
does not use ionizing radiation; and can evaluate function, perfusion and viability in the same 7 
investigation. Perfusion CMR requires the passage of a contrast agent bolus through the heart to 8 
be visualised over time. Typically a saturation prepared single-shot readout sequence is used to 9 
achieve adequate coverage and spatial and temporal resolution (7,8). Post-processing of CMR 10 
perfusion images can generate estimates of absolute myocardial blood flow (MBF). Absolute 11 
MBFs provide an objective measure of perfusion which does not require a healthy region of 12 
myocardium for visual comparison. They have been used to show diffuse perfusion changes due 13 
to smoking (9) and type 2 diabetes mellitus (10) and there is evidence to suggest that these 14 
measurements may bring improvements in diagnostic performance (11). However assessments of 15 
the diagnostic accuracy of MBF estimates have been limited to small studies (typically <50 16 
patients) (11–15). Perfusion is often expressed as myocardial perfusion reserve (MPR = stress 17 
MBF / rest MBF). However, it is unknown whether the use of MPR values improves diagnostic 18 
performance over stress perfusion measurements alone. If not, the time consuming rest perfusion 19 
scan could potentially be removed from the acquisition protocol without reducing the 20 
performance of the test (16,17).  21 
The primary objective of this study was to compare the sensitivity, specificity and diagnostic 22 
accuracy of expert visual analysis and MBF estimates against a reference standard of quantitative 23 
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coronary angiography (QCA). This was done using a large representative subsample of the CE-1 
MARC (clinical evaluation of magnetic resonance imaging in coronary heart disease) study (2). 2 
We hypothesised that quantitative CMR would have a higher diagnostic accuracy than visual 3 
analysis for identifying significant coronary artery stenosis. A secondary objective was to 4 
compare the diagnostic accuracy of MPR measurements, which use both rest and stress MBF 5 
data, with stress MBF measurements only. 6 
Methods 7 
Patients: The study protocol was approved by the national research ethics service. CE-MARC 8 
recruited patients with suspected angina pectoris, of which 676 had assessable CMR and 9 
angiography (2,18). For this sub-study 128 cases were randomly selected by an independent 10 
statistician from the CE-MARC population, such that the distribution of risk factors 11 
(hypertension, diabetes, smoking, age) and disease status (normal, single, double or triple vessel 12 
disease) was proportionate to those in the full population. This sub-sample contained 50 patients 13 
that have been included in a previous study (16). 14 
Image acquisition: Myocardial perfusion CMR and QCA data were acquired from each patient 15 
as previously described (2,18). All patients underwent invasive quantitative coronary 16 
angiography (QCA) within 32 days of their CMR examination. Adenosine (140 μg/kg/min) 17 
induced stress  imaging was performed at least 15 minutes before rest imaging.  Myocardial 18 
perfusion CMR was performed using a bolus intravenous injection of 0.05 mmol/kg 19 
dimeglumine gadopentetate (Magnevist®, Schering AG, West Sussex, UK) through an arm vein 20 
at an injection rate of 5ml/s. CMR imaging was carried out on 1.5T Philips Intera (Best, The 21 
Netherlands) equipped with 'Master' gradients (30 mT/m peak gradients and 150 mT/m/ms slew 22 
rate) using a 5-element cardiac phased-array coil and triggering performed by the 23 
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vectorcardiographic method.  Three short axes images were acquired using a T1-weighted 1 
saturation recovery turbo field echo (SR-TFE) imaging sequence. A shared (non-slice selective) 2 
saturation pulse was used giving pre-pulse delay times to the centre of k-space of 126ms, 272ms 3 
and 418ms for the basal, middle and apical slices respectively.  The image acquisition parameters 4 
were: TE 1.0 ms, TR 2.7 ms, flip angle 15°, SENSE factor 2, matrix 144 × 144, field of view 5 
320–460 mm, pixel size 2.2-3.2mm, slice thickness 10 mm and partial Fourier 0.67 giving a 6 
readout window of 130.2ms per slice. Imaging continued until the first pass had been observed to 7 
pass through the myocardium. The average number of frames in the perfusion series was 56 8 
(range 26, 78). 9 
Late gadolinium enhanced CMR was performed between 10-15 minutes after the rest perfusion 10 
study with a T1-weighted, segmented inversion-recovery gradient echo sequence; pulse sequence 11 
parameters: TE 1.9 ms, TR 4.9 ms, flip angle 15°, 10–12 short axis slices, single slice per breath-12 
hold, matrix 240 × 240, field of view 320–460 mm as per patient size. The optimal inversion 13 
time to null signal from normal myocardium was determined prior to the scan using a Look-14 
Locker approach (19).  15 
Image Analysis:  Quantitative CMR analysis was performed blinded to the results of all other 16 
investigations. Contours describing the myocardium and a region within the left ventricular 17 
blood pool, avoiding papillary muscles, were drawn using dedicated cardiac image analysis 18 
software (Mass 7.0, Medis, Leiden University, Leiden, The Netherlands).  Contours were copied 19 
to all time frames and manually adjusted for motion. Adjustments were limited to rigid 20 
translations only. Manual contouring took around one hour per patient.  The myocardium was 21 
subdivided into 6 circumferentially equidistant regions in the basal and mid slices and 4 in the 22 
apical slice according to the AHA standard (20). Individual perfusion data sets exhibiting 23 
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excessive (more than one frame) through plane motion (typically due to ECG gating failure) 1 
were visually identified and excluded prior to MBF quantitation. Signal versus time curves from 2 
the myocardium and blood pool were converted to contrast agent concentration curves assuming 3 
a linear signal response to contrast agent as described  previously (16). All pre-contrast signal 4 
estimates were taken from the stress study.  Values of 1435ms and 4.3 s
-1
.mM
-1
 were used for the 5 
blood T1 and contrast agent relaxivity respectively. To avoid remnant contrast agent from the 6 
stress perfusion scan affecting the rest perfusion analysis the pre-contrast signal intensity was 7 
subtracted from the rest perfusion curves prior to analysis. Myocardial blood flow (MBF) values 8 
were estimated using Fermi-constrained deconvolution (16,21). The arterial input function was 9 
taken from the basal slice. The pre-contrast baseline signal, end of first pass time point and the 10 
bolus arrival time delay between the blood pool and myocardial curves were calculated using 11 
previously described automated methods (16,22) 12 
Visual CMR perfusion images were jointly reported by two cardiologists (JPG, SP) with >6 13 
years’ experience in CMR at the time, and who were blind to the results of all other 14 
investigations. This was a perfusion only assessment that did not take into account cine, LGE or 15 
angiography images sets. Scores for hypoperfusion (ischaemia) of 0 (normal), 1 (equivocal), 2 16 
(subendocardial ischaemia), or 3 (transmural ischaemia) were given by visual comparison of 17 
stress and rest CMR perfusion scans (16 segments of the 17 segment AHA model, excluding the 18 
apical cap segment). To generate the receiver operator characteristic (ROC) curve the summed 19 
scores over all AHA segments were used. Diagnostic performance was ascertained from the 20 
ROC curve as the area under the curve (AUC) value. The cut-off value that generated the 21 
optimal sensitivity and specificity for the test was determined by maximising the Youden index 22 
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(23).  A separate assessment of LGE was performed with a score of 0 (none), 1 (1–25%), 2 (26–1 
50%), 3 (51–75%) or 4 (>75%) allocated to each segment of the AHA model.  2 
All x-ray angiograms were performed after CMR. Quantitative coronary angiography (QCA) 3 
analysis was performed off-line by a cardiologist blinded to the CMR results using QCAPlus 4 
software (Sanders Data Systems, Palo Alto, California, USA). Significant CAD was defined as 5 
≥70% diameter stenosis of a first order coronary artery measuring ≥2mm in diameter, or left 6 
main stem stenosis ≥50%. Single, double and triple vessel disease was defined as significant 7 
stenosis affecting one, two or three vessels respectively. Both visual CMR perfusion and QCA 8 
scores were taken from the original CE-MARC reports and were not reanalysed for this sub-9 
study. 10 
All perfusion results were compared to QCA on a per-patient basis. MPR values were calculated 11 
as the stress MBF estimate divided by the resting MBF estimate. To generate the ROC curve the 12 
AHA segment with the lowest perfusion measure (MPR or stress MBF) was used as the 13 
quantitative measure.  14 
Diagnostic performance was evaluated using ROC curve analysis taking the QCA diagnosis as 15 
the reference standard.  Diagnostic performance was first assessed in terms of the ability of the 16 
perfusion index to detect disease in any coronary artery. A separate assessment of the diagnostic 17 
performance for detecting disease in each individual coronary artery was performed using the 18 
AHA segmentation recommendations to map myocardial segments to individual coronary 19 
arteries. The number of detected perfusion defects that correctly corresponded to disease in the 20 
coronary artery specified by the AHA mapping was then assessed. 21 
Statistical Analysis: Categorical variables are expressed as numbers and percentages.  22 
Continuous variables are expressed as mean ± standard deviations unless otherwise stated. With 23 
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a sample size of 128 and using a correlation between the scores of r=0.45, the study was powered 1 
to detect a difference of 0.15 in the AUC values between ROC curves with a power of 80% at the 2 
5% significance level (24). ROC curves were generated using Analyse-it (Analyse-it Software 3 
Ltd. UK).  All other statistical analysis was carried out using SPSS (version 21.0, Chicago, IL).  4 
Comparison of ROC curves was performed using the DeLong method (25). There was no 5 
correction for multiple comparisons of AUC curves. Normally distributed data were compared 6 
using Student’s t-test.   7 
Results 8 
Baseline patient characteristics are summarised in Table 1. The study consisted of 128 patients 9 
(mean age 61 years; age range 37-77 years).  77 (60%) were male (mean age 61 years; age range, 10 
45-76 years) and 51 were female (mean age, 60 years; age range, 37-77 years).  There was no 11 
significant age difference between male and female groups (p=0.33). 42 patients had significant 12 
coronary artery disease as assessed by QCA and 86 did not. Four whole patient perfusion data 13 
sets (3%) were excluded from the study because of severe through plane motion caused by 14 
electrocardiographic (ECG) triggering failures (3 stress scans and 1 rest scan).  These consisted 15 
of one patient with single vessel disease, one with double vessel disease and two healthy patients 16 
as assessed by QCA. Post-exclusion, 40 patients with significant coronary heart disease and 84 17 
without remained for analysis. Analysis of late gadolinium enhancement images showed 33 18 
patients had evidence of myocardial scaring (infarct pattern).  19 
Mean global (i.e. mean MBF per slice averaged over all three slices) myocardial blood flow 20 
values over all three slices are shown in Table 2. Mean MBFs from healthy patients for each 21 
slice are shown in Table 3. Perfusion was significantly lower in ischaemic patients than in 22 
normal; Stress MBF 2.16 (0.70) ml/min/g vs. 3.00 (0.81) ml/min/g, (p<0.001) and MPR 1.86 23 
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(0.57) vs 2.31 (0.67), (p<0.001). Receiver operator characteristic curves for visual and 1 
quantitative perfusion analysis are shown in  2 
Figure 1. The sensitivity, specificity, area under the curve (AUC) and optimal cut-off values are 3 
shown in Table 4 and Table 5 shows the respective contingency tables The highest diagnostic 4 
accuracy was achieved using MPR measurements. There was no statistically significant 5 
difference in diagnostic performance between visual (AUC 0.88, cut-off 2.0) and quantitative 6 
analysis for MPR (AUC 0.89, cut-off 1.11; p=0.72) or stress MBF (AUC 0.87, cut-off 1.27 7 
ml/min/g; p=0.54). There was no significant difference in diagnostic accuracy between MPR and 8 
stress MBF quantitative ROC curves (p=0.79). 9 
Separate assessments for single, double and multi (double or triple) vessel disease patients are 10 
shown in Table 6. There was no significant difference between the diagnostic accuracy of visual 11 
and quantitative analysis in single, double or multi vessel disease groups. In 28 (70%) out of 40 12 
cases the minimum quantitative perfusion score mapped correctly to a coronary artery territory 13 
that contained a significant stenosis according to the AHA segmentation model. 8 out of 9 (89%) 14 
defects correctly corresponded to a stenosis in the LCX, 12 out of 19 (63%) correctly 15 
corresponded to a stenosis in the LAD and 8 out of 12 (70%) correctly corresponded to a stenosis 16 
in the RCA. Separate assessments for the individual coronary arteries are shown in Table 7. 17 
Quantitative measures (stress MBF or MPR) did not perform significantly better than visual 18 
analysis for any of the coronary arteries.  19 
Discussion 20 
The primary finding of this study is that quantitative myocardial perfusion analysis has a high 21 
diagnostic accuracy but does not out-perform expert visual analysis. In addition, diagnostic 22 
performance of quantitative perfusion was not significantly improved by including rest perfusion 23 
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measurements. This suggests that the rest perfusion acquisition may not be necessary for 1 
quantitative analysis, potentially saving time, expense (less contrast) and patient inconvenience. 2 
To the author’s knowledge this is the largest investigation into the diagnostic performance of 3 
quantitative CMR perfusion to date, around twice as large as the previous largest study with 4 
n=67 (11).  5 
The presence of myocardial infarction can make visual diagnosis of superimposed ischaemia 6 
challenging. In this study quantitation achieved a high diagnostic accuracy even though a 7 
significant number (thirty three) of cases in the study had myocardial infarction as assessed by 8 
LGE imaging. Therefore the quantitative diagnostic accuracy reported in this study supports the 9 
robustness of this technique in ‘real-world’ clinical cases.  10 
Our data showed comparable diagnostic accuracy in single and multi-vessel disease with visual 11 
or quantitative analysis  implying that there was no advantage in quantitative analysis in patients 12 
with different extents of CAD.  Furthermore, we found similar diagnostic accuracies for the 13 
ability of visual or quantitative analysis to detect perfusion defects in the three coronary arteries 14 
(LCX, LAD and RCA).  Although MPR appears to perform slightly better than visual or stress 15 
MBF analysis, especially at sensitivities above 80% (Figure 1), these differences were not 16 
statistically significant. The high diagnostic accuracy observed using stress MBF alone agrees 17 
well with previous studies that analysed stress only images using semi-quantitative, (6,26,27) 18 
visual (28,29) and quantitative analyses. These observations demonstrate that stress data alone 19 
can yield excellent diagnostic performance and a rest perfusion study may not be necessary in a 20 
standard protocol to detect or exclude CAD. MPR is a measure of the potential flow increase the 21 
myocardium has in reserve before maximal vasodilation occurs. Whereas stress perfusion is 22 
uncoupled from oxygen demand resting perfusion is not (6), so factors influencing resting 23 
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myocardial oxygen demand cannot be controlled for in a clinical setting. This uncontrolled 1 
aspect of the rest perfusion measurement may account for the fact that dividing by the rest MBF 2 
measurement did not improve diagnostic accuracy in our quantitative data.  3 
Our finding that the diagnostic performance of quantitative perfusion is comparable to, but not 4 
significantly better than, visual analysis is consistent with previous, smaller studies (13,15).  5 
However, Mordini at al. (11) did report a diagnostic advantage using quantitation. This may be 6 
due in part to the fact that Mordini measured the ratio between the endocardial segment and the 7 
median epicardial value and required at least two segments to fall below the threshold before a 8 
patient was classed as ischaemic, whereas our study used the minimum segmental MBF score. 9 
Our study did not replicate this transmural subdivision strategy due to concerns over increasing 10 
the noise in the signal versus time curves.   11 
MBF values in patients without ischaemia were comparable with those published in studies of 12 
healthy volunteers (30,31).  At 1.23ml/min/g the resting MBF is somewhat higher than most 13 
studies, due to non-linearity effects in the AIF, but still well within the range of MBF values 14 
quoted in the literature. The total exclusion rate was 3% (4/128). This compares favourably with 15 
other quantitative studies.; for instance, Patel et al (9) excluded 23% of patients and Costa et al 16 
(6) excluded 16%.  17 
The optimal threshold for abnormal perfusion from the ROC analysis was set at an MPR of 1.11 18 
and a stress MBF of 1.27 ml/min/g.  The MPR threshold is somewhat lower than other studies 19 
(Huber at al. 1.54 (17), Patel et al 1.55, (13)) possibly due to the high rest MBF measurements in 20 
our study.  The stress MBF threshold of 1.27 ml/min/g was somewhat lower than that of Mordini 21 
et al. at 1.58 ml/min/g (11), possibly because their model required two AHA segments below the 22 
cut-off threshold whereas our model only required one.  23 
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Limitations 1 
Perfusion CMR assesses myocardial ischaemia, whereas QCA is a measure of coronary artery 2 
stenosis, which is itself an imperfect reference standard. Thus, false-negative results could occur 3 
if lesions not causing ischaemia (as assessed by CMR) were judged clinically significant on the 4 
basis of angiographic stenosis severity.  Invasive measurement of fractional flow reserve is now 5 
the reference standard for the measurement of haemodynamic significance of a coronary artery 6 
stenosis, but was not routinely performed at the time of recruitment to the CE-MARC study. 7 
The combination of a 0.05mmol/kg contrast dose and a pre-pulse delay of 126ms yields a non-8 
linear signal response to contrast agent concentration in the AIF, resulting in an over-estimate of 9 
MBF. The lack of a linear AIF measurement constitutes a limitation to this retrospective dataset. 10 
This could potentially diminish the range of MBF estimates and reduce the performance of 11 
quantitative perfusion, including the benefits of rest perfusion. However, our analyses achieved a 12 
high sensitivity and specificity in agreement with other studies employing dual-bolus techniques 13 
implying that non-linearity errors have not profoundly affected the results.  This agrees with 14 
previous work directly comparing dual and single bolus strategies and finding no significant 15 
difference in diagnostic performance (32). 16 
The use of a shared pre-pulse to acquire all three perfusion slices results in different T1 contrast 17 
between the three image slices. This has been addressed by using the basal AIF for all three 18 
slices and by applying a linear correction to the myocardial curves. This approach may be subject 19 
to errors if the myocardial signal to concentration relationship is sufficiently non-linear, although 20 
there were no significant differences in MBF between the three slices in the study population 21 
(Table 3). 22 
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Manual correction for breathing motion introduces an extra source of error into the 1 
measurements as the signal curves can be contaminated by high signal blood pixels in the LV or 2 
other surrounding tissues deteriorating the results of MBF quantitation. Although care was taken 3 
to avoid these errors an automated, non-rigid registration might have improved our quantitative 4 
results. The use of quantitative perfusion analysis in clinical practice requires a known 5 
healthy/diseased threshold value.  Currently this value may vary between studies because of 6 
variations in MBFs due to differing methodologies. Before MBF measurements can be used 7 
widely standardisation of these methods and multi-centre studies are necessary to show that a 8 
single cut-off across different sites and CMR vendors is suitable and can still achieve the high 9 
diagnostic accuracies reported in this study. This is even more relevant if the rest perfusion 10 
measurement is to be discarded because expressing perfusion as a ratio can normalise systematic 11 
shifts in MBF, due to differences in methodology, that remain if a stress only perfusion 12 
measurement is used.  It also noteworthy that quantitative perfusion can impose limits on the 13 
acquisition such as lower contrast dose and reduced image T1-weighting that can force a 14 
reduction in image quality and or heart coverage, which may adversely affect visual assessment. 15 
Conclusions 16 
Quantitative myocardial perfusion has a high diagnostic accuracy for detecting coronary artery 17 
disease, but is not superior to expert visual analysis, even in multi-vessel disease. Rest perfusion 18 
data acquisition does not increase the diagnostic accuracy of quantitative myocardial perfusion 19 
and could be eliminated from the imaging protocol.   20 
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Perspectives 1 
Competency in Medical Knowledge 2 
This work has shown that quantitative myocardial perfusion estimates obtained from CMR have 3 
a high diagnostic accuracy equivalent to, but not better than, that of expert visual analysis. In 4 
addition, the use of a rest perfusion measurement did not improve diagnostic performance above 5 
stress perfusion quantitation alone. The clinical implications are that these observations support 6 
removal of rest perfusion imaging from the acquisition protocol.  7 
 8 
Translational Outlook 9 
For quantitative perfusion estimates to be accepted as a standard clinical tool a number of 10 
obstacles need to be overcome. Firstly, the time consuming analysis needs to be streamlined so 11 
that quantitative estimates are easily available to a non-expert user within a reasonable time 12 
frame. Secondly, diagnosis using quantitative measurement requires a known healthy/diseased 13 
cut-off value.  These cut-off points vary between studies because of the variation in quantitative 14 
values due to the wide range of methods used.  These include differences in contrast dose 15 
administered, CMR acquisition sequence, methods for correcting non-linearity between contrast 16 
agent concentration and signal intensity, motion correction and modelling methods used to 17 
generate the final flow value. If these measurements are to be used widely standardisation of 18 
these methods is required in order to reduce these variations. Multi-centre studies would then be 19 
necessary to show that a single cut-off across different sites and CMR vendors is suitable and can 20 
still achieve the high diagnostic accuracies reported in this study.  21 
  22 
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Figure 1 ROC curves for quantitative and visual analyses. ROC curves for visual analysis, 1 
myocardial perfusion reserve (MPR) and stress myocardial blood flow (MBF) showing 2 
diagnostic accuracy for detecting significant stenosis as assessed by QCA.  There was no 3 
statistically significant difference in diagnostic performance between visual and MPR (p=0.72) 4 
or stress MBF (p=0.54). 5 
 6 
 7 
  8 
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Table 1- Patient Characteristics 1 
Age [years] 61 ± 9  
Female 51 (40) 
Hypertension 65 (51) 
Diabetes 17 (13) 
Smoking 16 (13) 
1 vessel disease 23 (18) (1 excluded) 
2 vessel disease 15 (12) (1 excluded) 
3 vessel disease 4  (3) (0 excluded) 
Total patients with CAD 42 (33) (2 excluded) 
 2 
Data are mean + SD or number of cases (%) 3 
 4 
  5 
23 
 
Table 2: Quantitative perfusion results for ischaemic and non-ischaemic groups 1 
 Number of 
cases 
Stress MBF 
[ml/min/g] 
Rest MBF 
[ml/min/g] 
MPR 
Ischaemic 40 2.16 + 0.70 1.23 + 0.41 1.86 + 0.57 
Non Ischaemic 84 3.00 + 0.81 1.37 + 0.39 2.31 + 0.67 
All 124 2.73 + 0.87 1.32 + 0.40 2.17 + 0.67 
 2 
Data are mean + SD. 3 
MBF = myocardial blood flow, MPR = myocardial perfusion reserve 4 
 5 
  6 
24 
 
Table 3: Quantitative perfusion values by slice in healthy cases 1 
Slice Stress MBF 
[ml/min/g] 
Rest MBF 
[ml/min/g] 
MPR 
1 2.81 + 0.75 1.29 + 0.27 2.25 + 0.73 
2 3.15 + 0.65 1.41 + 0.38 2.34 + 0.55 
3 3.04 + 0.98 1.40 + 0.48 2.33 + 0.74 
 2 
Data are mean + SD. 3 
MBF = myocardial blood flow, MPR = myocardial perfusion reserve 4 
 5 
6 
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Table 4: Diagnostic performance of quantitative and visual methods to detect stenosis as 1 
measured by QCA. Scores need to be greater than the optimal cut-off value to classify the patient 2 
as ischaemic. 3 
Data are value (95% confidence interval) 4 
AUC = area under the curve, MBF = myocardial blood flow, MPR = myocardial perfusion 5 
reserve  6 
 AUC Sensitivity (%) Specificity (%) Optimal cut-off 
Stress MBF 
[ml/min/g] 
0.87 (0.80, 0.94) 75.0 (61.6, 88.4) 91.7 (85.8, 97.6) 1.27 
MPR 0.89 (0.83, 0.96) 87.5 (77.3, 97.7) 84.5 (76.8, 92.3) 1.11 
Visual 0.88 (0.81, 0.95) 81.0 (69.1, 92.8) 86.0 (78.7, 93.4) 2.00 
26 
 
Table 5: Contingency tables for Stress MBF, MPR and visual analysis 1 
a) 2 
CAD as assessed 
by: 
X-ray (QCA) 
+ - 
M
R
I 
(M
P
R
) 
+ 35; 0.67 (0.21) 13; 0.75 (0.18) 
- 5; 1.39 (0.24) 71; 1.61 (0.39) 
b) 3 
CAD as assessed 
by: 
X-ray (QCA) 
+ - 
M
R
I 
(s
tr
es
s 
M
B
F
) 
+ 30; 0.76 (0.29) 7; 0.94 (0.23) 
- 10; 1.99 (0.54) 77; 2.17 (0.62) 
c) 4 
CAD as assessed 
by: 
X-ray (QCA) 
+ - 
v
is
u
al
 + 34; 11.71 (6.59) 12; 6.58 (4.10) 
- 8; 0.75 (0.89) 74; 0.31 (0.64) 
 5 
Contingency tables showing number of cases, mean value and standard deviation of the values 6 
for a) MPR, b) stress MBF and c) visual analysis. 7 
Data values are: number of cases; mean (standard deviation).  Symbols ‘+’ and ‘-‘ correspond to 8 
positive and negative assessments for coronary artery disease respectively. 9 
 10 
  11 
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Table 6: Area under the curve (AUC) values for single, double and multiple vessel disease. 1 
 Single vessel disease Double vessel disease Multiple vessel 
disease 
Stress MBF 0.93 (0.85, 1.0) 0.81 (0.67, 0.95) 0.83 (0.71, 0.95) 
MPR 0.88 (0.78, 0.98) 0.94 (0.84, 1.00) 0.91 (0.82, 1.00) 
Visual 0.89 (0.80 , 0.98) 0.85 (0.72, 0.98) 0.87 (0.76, 0.98) 
No. of cases 22 14 18 
Data are values (95% confidence interval) 2 
MBF = myocardial blood flow, MPR = myocardial perfusion reserve.  3 
Multiple vessel disease is defined as a patient with either double or triple vessel disease. 4 
  5 
28 
 
Table 7: Area under the curve (AUC) values for quantitative perfusion for individual coronary 1 
arteries 2 
 LCX LAD RCA 
Stress MBF 0.75 (0.62, 0.89) 0.76 (0.64, 0.89) 0.83 (0.69, 0.97) 
MPR 0.74 (0.60, 0.87) 0.77 (0.65, 0.89) 0.73 (0.56, 0.89) 
Visual 0.69 (0.56, 0.83) 0.77 (0.64, 0.88) 0.73 (0.57, 0.89) 
 3 
Data are value (95% confidence interval) 4 
LCX = left circumflex, LAD = left anterior descending, RCA = right coronary artery, MBF = 5 
myocardial blood flow, MPR = myocardial perfusion reserve. 6 
